AMLX NASDAQ
Amylyx Pharmaceuticals, Inc.
1W: +0.4%
1M: -20.5%
3M: -0.6%
YTD: +22.0%
1Y: +152.4%
3Y: -48.8%
$13.58
-0.35 (-2.51%)
Weekly Expected Move ±5.5%
$12
$13
$13
$14
$15
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (29)
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 2026 Results and Pipeline Progress
Amylyx (AMLX) Q1 2026 Earnings Transcript
12 Health Care Stocks Moving In Friday's Pre-Market Session
Amylyx Pharmaceuticals GAAP EPS of -$0.37 misses by $0.01
[10-Q] Amylyx Pharmaceuticals, Inc. Quarterly Earnings Report - Stock Titan
Stock Traders Purchase Large Volume of Amylyx Pharmaceuticals Call Options (NASDAQ:AMLX)
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Consensus Rating of “Moderate Buy” from Analysts
437,391 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by Ally Bridge Group NY LLC
Amylyx Pharmaceuticals, Inc. $AMLX Shares Acquired by Alpha Wave Global LP
HC Wainwright Brokers Increase Earnings Estimates for AMLX
Amylyx anticipates LUCIDITY trial results in Q3 2026 while advancing PBH market strategy
Amylyx (AMLX) Q4 2025 Earnings Call Transcript
Amylyx Pharmaceuticals GAAP EPS of -$0.30 beats by $0.04
This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday
Earnings Scheduled For March 3, 2026
Here are the major earnings before the open Tuesday
Amylyx Pharmaceuticals Q4 2025 Earnings Preview
A Look at Amylyx Pharma's Upcoming Earnings Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Financial Survey: Amylyx Pharmaceuticals (NASDAQ:AMLX) vs. Theravance Biopharma (NASDAQ:TBPH)
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?
Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance?
HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS